OxyContin maker asks judge to toss case brought by city

March 21, 2017 by Phuong Le
-In this Feb. 16, 2017, file photo, Everett Mayor Ray Stephanson sits in his corner office overlooking downtown Everett, Wash. Stephanson is suing pharmaceutical giant Purdue Pharma, becoming the first city to try to hold the maker of OxyContin accountable for damages to his community. Connecticut-based Purdue Pharma argued in court documents filed Monday, March 20, 2017, there is no legal basis for such a lawsuit. (AP Photo/Elaine Thompson, file)

The maker of the pain medication OxyContin has asked a federal judge in Seattle to throw out a Washington city's lawsuit that seeks to hold the drugmaker responsible for allowing its pills to flood the black market and into Everett.

Purdue Pharma argued in filed Monday that there is no basis in law for a municipality to bring such an action against a pharmaceutical manufacturer.

Everett, a city of about 108,000 north of Seattle, sued the Connecticut-based company in January seeking to hold it accountable for the social and economic damages to the community due to of the . The city alleged that Purdue knowingly allowed pills to be funneled into the and into the city and did nothing to stop it.

The city's lawsuit which accuses Purdue of gross negligence and nuisance was initially filed in state court but has moved to federal court in Seattle.

Purdue makes several arguments in asking U.S. District Judge Ricardo S. Martinez to dismiss all claims. It contends that the city's claim that Purdue failed to report suspicious flows to authorities isn't reasonable given other court filings that demonstrate law enforcement knew and was already investigating criminal trafficking at issue. Purdue also maintains that it did not breach any legal duty to the city and that the city does not have standing to make claims based on a consent judgment that the company entered into with the state of Washington.

In 2007, Purdue settled with Washington and other states that claimed the company aggressively marketed OxyContin to doctors while downplaying the addiction risk. As part of that settlement, the company agreed to continue an internal program to identify potential diversion or abuse.

Purdue also says that the lawsuit should be dismissed because the city hasn't brought a claim that shows a direct relationship between the company's conduct and the alleged harms it outlined.

A spokeswoman for Everett did not immediately respond to a request for comment Tuesday. But Mayor Ray Stephanson previously said he thinks the city has a strong case.

"We wouldn't have followed this lawsuit if we didn't believe we could prevail," he said in an interview last month. "We believe our case is strong and we believe our arguments will be convincing."

Stephanson said the opioid crisis caused by "Purdue's drive for profit" has overwhelmed the 's resources, stretching everyone from first responders to park crews who clean up discarded syringes. He said the community has been significantly damaged and should be made whole.

Explore further: US city sues maker of painkiller OxyContin

Related Stories

US city sues maker of painkiller OxyContin

January 20, 2017
A small US city on Thursday filed a lawsuit against Purdue Pharma, the maker of the pain reliever OxyContin, accusing the company of helping fuel an opioid crisis that has devastated the town.

Pfizer agrees to note addiction risks in opioid marketing

July 6, 2016
The city of Chicago and Pfizer announced an agreement Wednesday committing the drugmaker to disclosing the serious risks of addiction in its marketing of prescription opioid painkillers.

Supreme Court sympathetic to Microsoft in Xbox owners' suit (Update)

March 21, 2017
The Supreme Court suggested Tuesday that it is sympathetic to Microsoft Corp. in a dispute with disgruntled owners of the Xbox 360 video-game system who sued saying the console has a design defect that scratches game discs.

Judge tosses lawsuit over NYC's payphone-turned-Wi-Fi plan

July 12, 2016
A federal judge has dismissed a lawsuit challenging New York City's push to turn payphones into Wi-Fi hotspots.

Study: Heroin resurgence an 'unintended consequence' of attempt to curb OxyContin abuse

January 13, 2017
In an attempt to stem abuse of OxyContin, Purdue Pharma spent a decade and several hundred million dollars developing a version of the painkiller that was more difficult to snort, smoke or inject. Since those "abuse-deterrent" ...

Recommended for you

Novel botulinum toxin compound relieves chronic pain

July 18, 2018
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, ...

FDA recalls heart medication valsartan, citing cancer concerns

July 17, 2018
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Study reveals opioid patients face multiple barriers to treatment

July 12, 2018
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

travispaul309
1 / 5 (1) Mar 22, 2017

My grandma has Parkinson's disease, she is about 75 years old it was detected 7 years ago. it was very difficult to live for her, because of stiff muscles she can't even move. L-dopa and carbidopa medicines are given, but won"t give much relief. She can"t eat food and the skin is damaging forming ganglia.my friend introduced me to perfecthealthherbalmedicine,he said perfecthealthherbalmedicine cure his father of Parkinson and COPD,so i decided to give it a try,so i emailed them,they replied and ask for my grandma details,which i sent to them via email:perfecthealthherbalmedicine @ gmail. com,website:www. perfecthealthherbal. weebly com. then i purchased the herbal medicine for Parkinson diseases,after purchasing,the herbal medicine was shipped to my address,which i received within 2 days,when i received the herbal medicine i called them,and they told me how to use it,after 5 weeks of usage my grandma stiff muscles was released and she started walking,eat properly

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.